Efficacy and safety of REGN9933<sup>A2</sup> and REGN7508<sup>Cat</sup> for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
Regeneron Pharmaceuticals
Jeffrey I Weitz; Aaron P Kithcart; Meagan P O'Brien; Oren Levy; Ethan Marin; Margaret Onisko; Kusha A Mohammadi; Dateng Li; Karoline A Meagher; Hannah H Chang; Benjamin A Olenchock; David E Gutstein; Annelise Segers; Robin S Roberts; Marc P Bonaca; Gary E Raskob